Health Net ($42.64) spiked to a 52-week high at $45.61 on July 24, and declined to its 50-day SMA at $41.53, trading as low as $41 on Friday. The stock is well above its 200-day SMA at $34.53.

Analysts expect the company to report earnings of 56 cents per share. Health Net has a 12-month trailing P/E ratio of 21 and doesn't pay a dividend.

The weekly chart shifts to negative given a close this week below its five-week MMA at $41.85. Quarterly and semiannual value levels are $38.49 and $37.78, respectively, with a monthly pivot at $42.16 and weekly risky level at $44.12.

Ralph Lauren ($156.30) has been below its 200-day SMA at $161.57 since July 10, trading as low as $153.87 on Friday.

Analysts expect the company to report earnings of $1.75 per share. It has a 12-month trailing P/E ratio of 18.7 and dividend yield of 1.2%.

The weekly chart is negative with its five-week MMA at $157.06 and the 200-week SMA at $151.64. A monthly value level is $142.45 with an annual pivot at $154.30 and weekly and annual risky levels at $160.85 and $168.38, respectively.

Molson Coors ($67.90) set an all-time intraday high at $75.55 on June 20, and traded as low as $67 on Friday, which was well below its 50-day SMA at $70.77 and well above its 200-day SMA at $60.02.

Analysts expect the company to report earnings of $1.44 per share. It has 12-month trailing P/E ratio of 16.3 and dividend yield of 2.2%.

The weekly chart is negative with its five-week MMA at $69.75. Semiannual and annual value levels are $62.38 and $60.54, respectively, with a quarterly pivot is $67.88 and monthly and weekly risky levels at $71.00 and $76.99, respectively.

Visteon ($98.81) set an all-time intraday high at $100.79 on July 7, and traded as low as $94.23 on Thursday, compared with its 50-day SMA at $95.65. The stock is well above its 200-day SMA at $85.92.

Analysts expect the company to report earnings of 75 cents per share. It has a 12-month trailing P/E ratio of 22 and doesn't pay a dividend.

The weekly chart is neutral with its five-week MMA at $96.45 and its 200-week SMA down at $62.97. Semiannual value levels are $93.29 and $72.29, with a monthly pivot at $98.60 and weekly and quarterly risky levels at $99.29 and $107.56, respectively.

Abercrombie Is Seen on the Recovery Road

If you liked this article you might like

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Alibaba, Qorvo, Abbott Laboratories, Square: 'Mad Money' Lightning Round

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round